Main menu

Section menu

The LEO Foundation

Since 1984, LEO Pharma A/S has been fully owned by the LEO Foundation – making it completely independent of outside investment from shareholders. This allows us to focus our commitment on one stakeholder: patients. 100% of our profits are reinvested in LEO Pharma to discover new patient solutions.

The LEO Foundation is an independent, private institution, which provides the stability needed to plan long-term research and development programs. Without outside stakeholders or interests, we can make fast decisions, foster new ideas, and encourage collaboration across the company.